Dr. Rachel D Lee PHARM.D

Recommended Articles

• Keeping Diabetes Under Control in the Winter

  According to several studies, the largest number of diabetes diagnoses take place during the colder months of the year. Here's another fact: Finland, and other colder areas in the world, have the largest number of people with type type 1 diabetes. So, what exactly is this relationship between the...

• What is a Low Glycemic Index Diet?

  What is a low glycemic diet?Low glycemic diet, also known as glycemic index diet or GI diet, is the basis of a number of popular diet plans for losing weight. Low glycemic diet is based on the glycemic index of different food materials.Glycemic index Glycemic index is the list which classifies...

• Understanding the Connection Between Sleep Apnea and Heart Conditions

  Researchers have found that obstructive sleep apnea (OSA) is linked to cardiometabolic dysfunction. The study, seen in the Journal of Clinical Endocrinology and Metabolism, attempts to provide an explanation as to why sleep apnea patients often have problems associated with their heart.  Up until...

• Can a Diet Help to Manage Fibromyalgia Symptoms?

  Fibromyalgia is a chronic disease characterized by severe pain in the muscles and extreme fatigue. The actual cause of the disease is not clear. Many are looking at alternative treatment methods to alleviate the symptoms that are very frustrating. Many patients have reported that eating certain...

• Understanding Peripheral Neuropathy in Adult Lupus Patients

  Systemic Lupus Erythematosus (SLE) is an autoimmune disease that has been affecting millions of people, both young and old worldwide. Numerous studies about this disease have been conducted by different academic, pharmaceutical, and medical organizations. Over the course of continuous and extensive...

• FDA Approves Baricitinib for Adults with Active Rheumatoid Arthritis

  On June 1st of 2018, the US Food and Drug Administration (FDA) approved Olumiant (Baricitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more TNF inhibitor therapies. “We are pleased to provide RA...